Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage

Source Motley_fool

Key Points

  • Medicare currently covers GLP-1s to treat conditions like Type 2 diabetes.

  • It will begin covering the drug for weight loss with prior authorization beginning in July 2026.

  • It'll be up to Part D plan providers to decide whether to cover the drug in 2027 and beyond.

  • The $23,760 Social Security bonus most retirees completely overlook ›

Medicare beneficiaries are reaping the benefits of negotiated rates on 10 popular prescription drugs this year, but there are some notable absences on that list, specifically GLP-1 medications. Though these drugs have become extremely popular for weight loss, Medicare doesn't currently cover them for this purpose.

Fortunately, we're only a few months away from a shift that will make these medications a lot more accessible to you if you're on Medicare. Here's what you need to know.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Older patient talking to a doctor.

Image source: Getty Images.

Medicare doesn't currently cover GLP-1s for weight loss

Medicare currently covers drugs like Ozempic and Wegovy for specific purposes, like managing Type 2 diabetes. If you have a condition like this, you may be able to get one of these medications under your Medicare Part D plan right away.

But if you just want a GLP-1 to help you lose weight, you're out of luck for the moment. Medicare doesn't cover these drugs for weight loss purposes, so you'll either need to cover them out of pocket -- which can cost almost $1,000 per month -- or use another health insurance plan if you have one available.

Fortunately, all that will change in a few months. Medicare is changing its rules for GLP-1 coverage, and this could give some beneficiaries access to the drugs for weight loss as soon as July 2026.

Medicare will start covering GLP-1s for weight loss later this year

Medicare is launching the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) model in January 2027. Under this model, you'll be able to get coverage for GLP-1s on some Medicare Part D plans next year. However, it'll be up to each private health insurer offering the Part D plans to decide whether to include this coverage.

Beginning in July 2026, Medicare will begin offering a GLP-1 bridge to give beneficiaries earlier access to these medications. To be eligible, you must have a Medicare Part D plan or a Medicare Advantage plan that includes prescription drug coverage. You'll also need your healthcare provider to submit a prior authorization form to Medicare.

If you have any questions, consider reaching out to the Center for Medicare & Medicaid Services or your Part D plan administrator for clarification. You'll also want to pay careful attention to which Part D plan you choose during the next Open Enrollment Period. If you opt for a plan without GLP-1 coverage, your retirement healthcare costs could skyrocket in 2027.

The $23,760 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income.

One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
3 Meme Coins To Watch In The Final Week Of March 2026The final week of March 2026 is drawing attention to the meme coin sector. Select tokens are showing chart structures that stand apart from the broader market pullback.BeInCrypto has analysed three su
Author  Beincrypto
Mar 24, Tue
The final week of March 2026 is drawing attention to the meme coin sector. Select tokens are showing chart structures that stand apart from the broader market pullback.BeInCrypto has analysed three su
placeholder
3 Altcoins To Watch In The Final Week Of March 2026Some altcoins are standing at technical and fundamental inflection points as March 2026 enters its final week. Each faces a near-term catalyst that could resolve their chart structures in one directio
Author  Beincrypto
Mar 24, Tue
Some altcoins are standing at technical and fundamental inflection points as March 2026 enters its final week. Each faces a near-term catalyst that could resolve their chart structures in one directio
placeholder
Bittensor (TAO) Rises 18%, Now Faces 4-Month-Old Barrier As Price Crosses $300Bittensor (TAO) is trading at $308, up 5.05% on the day and 18% over 24 hours, crossing the $300 level for the first time since late November 2025. The move has brought TAO directly into a confluence
Author  Beincrypto
Yesterday 01: 52
Bittensor (TAO) is trading at $308, up 5.05% on the day and 18% over 24 hours, crossing the $300 level for the first time since late November 2025. The move has brought TAO directly into a confluence
placeholder
NVIDIA Stock Price Bleeds Despite AGI Breakthrough Comments from CEONVIDIA (NVDA) stock price trades near $175, down roughly 9% over the past month. The stock opened the week flat after failing to reclaim $176 in the prior session. Since late October 2025, NVDA has be
Author  Beincrypto
Yesterday 01: 52
NVIDIA (NVDA) stock price trades near $175, down roughly 9% over the past month. The stock opened the week flat after failing to reclaim $176 in the prior session. Since late October 2025, NVDA has be
placeholder
Ethereum Price’s Climb Above $2,500 Requires Crossing This “Red Circle”Ethereum (ETH) is trading at $2,187, recovering inside a rising channel after pulling back from a March high near $2,393. Two on-chain signals and a clear technical resistance zone now frame exactly w
Author  Beincrypto
9 hours ago
Ethereum (ETH) is trading at $2,187, recovering inside a rising channel after pulling back from a March high near $2,393. Two on-chain signals and a clear technical resistance zone now frame exactly w
goTop
quote